Henry Schein Inc. stock outperforms competitors on strong trading day
Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.
Unveiling Henry Schein (HSIC) Q4 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during ...
Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Savant Capital LLC
Savant Capital LLC boosted its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 43.9% in the 4th quarter, ...
Fintel on MSN6d
Wells Fargo Initiates Coverage of Henry Schein (HSIC) with Equal-Weight Recommendation
Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Chevy Chase Trust Holdings LLC Sells 2,734 Shares of Henry Schein, Inc. (NASDAQ:HSIC)
Chevy Chase Trust Holdings LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the ...
Henry Schein Inc. stock underperforms Friday when compared to competitors
Henry Schein Inc. closed 8.02% below its 52-week high of $82.63, which the company reached on February 27th.
medtechdive1d
Philips expects sales struggles in China to continue in 2025
Philips forecast a double-digit sales decline in China for the first half of 2025 after reporting “significant deterioration” ...
medtechdive22h
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...